(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.88% $ 107.34
Live Chart Being Loaded With Signals
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery...
Stats | |
---|---|
Tagesvolumen | 852.00 |
Durchschnittsvolumen | 934.00 |
Marktkapitalisierung | 9.60B |
EPS | $1.030 ( 2023-06-30 ) |
Last Dividend | $1.174 ( 2023-03-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 32.33 |
ATR14 | $0.276 (0.26%) |
Carl Zeiss Meditec AG Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Carl Zeiss Meditec AG Finanzdaten
Annual | 2023 |
Umsatz: | $2.09B |
Bruttogewinn: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2023 |
Umsatz: | $2.09B |
Bruttogewinn: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2022 |
Umsatz: | $1.90B |
Bruttogewinn: | $1.13B (59.26 %) |
EPS: | $3.29 |
FY | 2021 |
Umsatz: | $1.65B |
Bruttogewinn: | $967.21M (58.73 %) |
EPS: | $2.64 |
Financial Reports:
No articles found.
Carl Zeiss Meditec AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.174 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.527 | 2013-03-01 |
Last Dividend | $1.174 | 2023-03-23 |
Next Dividend | $0 | N/A |
Payout Date | 2023-04-11 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | $7.38 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 3.69 | |
Div.Growth Potential Score | 4.66 | |
Div. Directional Score | 4.17 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
MUEL | Ex Dividend Junior | 2023-08-28 | Sporadic | 0 | 0.00% | |
CNTHP | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
SWRAY | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
HNFSA | Ex Dividend Junior | 2023-08-09 | Quarterly | 0 | 0.00% | |
ATDRY | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
OSCUF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
DQJCF | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
TSGTY | Ex Dividend Knight | 2023-06-23 | Annually | 0 | 0.00% | |
JDVB | Ex Dividend Knight | 2023-07-27 | Quarterly | 0 | 0.00% | |
BMBN | Ex Dividend Knight | 2023-06-30 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.134 | 1.500 | 9.62 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 24.02 | 1.000 | 2.22 | 2.22 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.33 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.78 | 3.78 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.196 | 1.000 | 8.08 | 8.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.28 | 1.000 | 6.84 | 0 | [1 - 100] |
returnOnEquityTTM | 0.134 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.55 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.189 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -28.41 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.112 | 1.000 | 9.71 | 0 | [0.1 - 0.5] |
Total Score | 4.66 |
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.